Key result
Probucol significantly attenuated the myocardial effects of adriamycin, improved left ventricular function, and lowered mortality in rats.
Why the study?
Does probucol prevent adriamycin-induced cardiomyopathy and improve cardiac function in rats?
Population
Rats treated with adriamycin (cumulative dose 15 mg/kg IP over 2 weeks) to induce cardiomyopathy.
Comparison
Probucol administered in six equal injections… vs Adriamycin treatment alone.
Design
Preclinical
Follow-up
3 weeks posttreatment
Authors
Loading...
Cautions against clinical use without human trials; extends preclinical evidence for antioxidants in anthracycline cardiotoxicity.
Does probucol prevent adriamycin-induced cardiomyopathy and improve cardiac function in rats?
Probucol protects against adriamycin-induced cardiomyopathy in rats by preserving endogenous antioxidant status.
Siveski-Iliskovic et al. (1994) studied Adriamycin-induced cardiomyopathy. Probucol vs. Adriamycin alone was evaluated. Probucol significantly attenuated the myocardial effects of adriamycin, improved left ventricular function, and lowered mortality in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: